• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

August 23, 2024 By SPINEMarketGroup

Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.

Lumbar spinal stenosis affects millions of people globally and is a leading cause of pain and disability. Patients today are seeking minimally invasive treatment options, valuing reduced recovery times and quicker returns to daily life. Vertos Medical’s mild® procedure provides a solution for pain relief and may improve mobility1,2 without the need for major surgery.

“We are committed to helping customers restore patients’ quality of life with interventional solutions to address chronic pain,” said Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker.
“This acquisition strengthens our minimally invasive pain management portfolio with differentiated treatments and expands our reach across ambulatory surgery centers.”

“Allowing patients to get back to what matters most to them is what matters most to us,” said Eric Wichems, Vertos Medical’s Chief Executive Officer. “Stryker’s mission and focus on interventional solutions provides an opportunity to further improve patients’ quality of life.”

This transaction is subject to customary closing conditions. Stryker and Vertos Medical Inc. will continue to operate as separate entities and proceed with business as usual until the transaction closes.

About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.

Media contact
Beth Sizemore
Sr. Director, Strategic Communications
beth.sizemore@stryker.com

References

  1. Deer TR, Chafin TB, Costandi SJ, Qu H, Kim C, Jassal N, Patel K, Calodney A. The MOTION study: Two-year results of a real-world randomized controlled trial of the mild® procedure for treatment of lumbar spinal stenosis. Pain Pract. 2024 Jan;24(1):109-119.Deer TR, Costandi SJ, Washabaugh E, Chafin TB, Wahezi SE, Jassal N, Sayed D. The MOTION Study: A Randomized Controlled Trial with Objective Real-World Outcomes for Lumbar Spinal Stenosis Patients Treated with the mild® Procedure: One-Year Results. Pain Med. 2022 Apr 8;23(4):625-634.

Related Posts:

  • Vertos Medical
  • Stryker announces definitive agreement to acquire…
  • Stryker Corporation

Filed Under: NEWS Tagged With: 2024

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical and Synaptive: Why the Rumors Deserve…
  • What Globus Medical Really Bought With Higgs Boson Health
  • BROCHURES
  • Globus Medical Announces Acquisition of Higgs Boson…
  • Neck and Neck: Is Globus Finally About to Overtake…
  • Who Runs DePuy Synthes? The CEO Fight That Killed…
  • Globus Medical to Showcase SCRIPT™ Patient-Specific…
  • J&J’s $21B DePuy Synthes Bet Could End in…
  • Federal Circuit Backs Globus Medical in Spinal…
  • Centinel Spine Files for NYSE IPO After 42% Jump in…
  • COMPANIES
  • Do Spine Companies Really Need So Many Implants?…
  • Record Earnings, Discount Valuation: What Globus…
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Globus Medical Reports Third Quarter 2026 Results…
  • New CFO, New AI Chief and a Patent Fight: What Is…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • CD HORIZON® SOLERA™ System
  • 3D-Printed Cages Are Everywhere. Has the Technology…
  • Top Expandable Cages of 2025: Which Lumbar Implants…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Globus Medical Acquires Synaptive Medical,…
  • SYMPHONY Occipito-Cervico-Thoracic (OCT) System
  • What Is a Spine Hub, and Why Did Avesi Invest in New…
  • Whatever Happened to the Translational Cervical…
  • Forty Cervical Discs, One 3% Market: The Fight to…
  • Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
  • FDA clears Solco’s Blue Dolphin cage for minimally…
  • Thinking About a Spine Robot? Your 2026 Guide to the…
  • Carlsmed, Inc. Files Patent Infringement Lawsuit…
  • LAST 5 VIDEOS PUBLISHED

    1. GS Medical: QUASAR™ Stand-Alone ACIF
    2. SI-BONE: iFuse Granite Onyx™
    3. NovaSpine: DIVA Cervical
    4. Xenix Medical: Riva Modular Fixation System
    5. Spinal Elements: Overwatch® PCF

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup